Fundz

Cycuria Therapeutics has received public grant funding to expand its operations and development efforts. The exact amount remains undisclosed.

PRIVATEApr 28, 2025

Round Type

Grant

GrazBiotechnologyHealth CareTherapeutics

Investors

Wieland CapitalAWS (Austria Wirtschaftsservice Gesellschaft mbH)AwsWieland Capital (Wpmb Gmb H)Ffg (Forschungs Förderungs Gesellschaft)

Description

Cycuria Therapeutics, a Graz, Austria-based preclinical biotechnology company, received grant funding from FFG and AWS. This funding will be used to further its operations and development efforts for novel biologics targeting tumour cells. Cycuria's lead asset, CUR-101, aims to treat acute myeloid leukaemia. The grant follows a previous Seed investment from Wieland Capital.

Quick answer

Cycuria Therapeutics raised an undisclosed amount in a Grant round, dated April 28, 2025. Investors: Wieland Capital, AWS (Austria Wirtschaftsservice Gesellschaft mbH), Aws, Wieland Capital (Wpmb Gmb H) and Ffg (Forschungs Förderungs Gesellschaft). Cycuria Therapeutics is based in Graz, Styria, Austria.

How much did Cycuria Therapeutics raise?
Cycuria Therapeutics raised an undisclosed amount in a Grant round on April 28, 2025.
Who invested in Cycuria Therapeutics?
Wieland Capital, AWS (Austria Wirtschaftsservice Gesellschaft mbH), Aws, Wieland Capital (Wpmb Gmb H) and Ffg (Forschungs Förderungs Gesellschaft) are named as investors in this round.
What does Cycuria Therapeutics do?
Cycuria Therapeutics is a preclinical stage biotechnology company based in Graz, Austria.
Where is Cycuria Therapeutics based and how big is it?
Cycuria Therapeutics is based in Graz, Styria, Austria. Fundz records about 6 employees.
Who are the decision-makers at Cycuria Therapeutics?
Fundz holds 1 contact at Cycuria Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Cycuria Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • ADC Therapeutics raised $100M (Private Equity) on June 12, 2025.
  • Ensho Therapeutics raised $23M on June 12, 2025.
  • Mezzion Pharma raised $20M (Funding Round) on June 11, 2025.
  • Elkedonia raised $13M (Seed) on June 11, 2025.
  • Synaptogenix raised $5.5M on June 9, 2025.
  • Gradalis raised $13M on June 5, 2025.

Who to call at Cycuria Therapeutics, and when

A new round usually means Cycuria Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cycuria Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cycuria Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cycuria Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cycuria Therapeutics

Location

Graz, Styria, Austria

About

Cycuria Therapeutics is a preclinical stage biotechnology company based in Graz, Austria. The company is developing novel biologics that selectively target both tumour cells and tumour stem cells while preserving the creation of healthy new blood cells. Its lead asset, CUR-101, is a novel protein-based targeted therapy for acute myeloid leukaemia (AML). The therapeutic rationale behind its approach has potential applications in other blood cancers and hard-to-treat solid cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cycuria Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cycuria Therapeutics's next move

See what Strategic adds

Cycuria Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.